| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$224 |
Resubmission of Notice of Change in Substantial Holding
|
2 Oct 2025 9:51AM |
$0.255 |
$0.215 |
fallen by
15.69%
|
|
| Canyon Resources Ltd (CAY) ORDINARY FULLY PAID |
Materials |
$495 |
Tranche 1 Equity Raising Completed and Cleansing Notice
|
2 Oct 2025 9:50AM |
$0.245 |
$0.240 |
fallen by
2.04%
|
|
| Somerset Minerals Limited (SMM) ORDINARY FULLY PAID |
Materials |
$20 |
Application for quotation of securities - SMM
|
2 Oct 2025 9:50AM |
$0.015 |
$0.017 |
risen by
13.33%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$224 |
Ceasing to be a substantial holder
|
2 Oct 2025 9:49AM |
$0.255 |
$0.215 |
fallen by
15.69%
|
|
| Octava Minerals Limited (OCT) ORDINARY FULLY PAID |
Materials |
$6 |
CSIRO Testwork Confirms Excellent Bio-Leaching at Byro
|
2 Oct 2025 9:49AM |
$0.063 |
$0.055 |
fallen by
12.70%
|
|
OCT - Price-sensitive ASX Announcement
Full Release
Key Points
- Excellent recovery rates for rare earth elements and battery metals.
- CSIRO conducted successful bioleaching tests using microbial cultures.
- Plans to acquire 100% ownership of the Byro Project.
- Byro Project located in Western Australia with existing infrastructure.
- Bio-mining offers sustainability and cost advantages over traditional methods.
- Further scale-up and optimization of bioleaching testwork planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$6,315 |
Notification regarding unquoted securities - CGF
|
2 Oct 2025 9:48AM |
$8.660 |
$9.130 |
risen by
5.43%
|
|
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$108 |
CLDN18.2 CAR-T cells eliminate pancreatic cancer cells
|
2 Oct 2025 9:48AM |
$0.097 |
$0.090 |
fallen by
7.22%
|
|
ALA - Price-sensitive ASX Announcement
Full Release
Key Points
- Arovella's CLDN18.2 CAR demonstrated robust elimination of pancreatic cancer cells.
- The study used the PaTu8892S cell line, showing potent activity of the CLDN18.2 CAR.
- Arovella will incorporate the CLDN18.2 CAR into their iNKT cell platform.
- Upcoming in vivo studies will target pancreatic and gastric cancers.
- The CLDN18.2 CAR-iNKT cells are expected to outperform CAR-T cells.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$224 |
Becoming a substantial holder
|
2 Oct 2025 9:47AM |
$0.255 |
$0.215 |
fallen by
15.69%
|
|
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$6,315 |
Notification regarding unquoted securities - CGF
|
2 Oct 2025 9:47AM |
$8.660 |
$9.130 |
risen by
5.43%
|
|
| Challenger Limited (CGF) ORDINARY FULLY PAID |
Financials |
$6,315 |
Notification of cessation of securities - CGF
|
2 Oct 2025 9:45AM |
$8.660 |
$9.130 |
risen by
5.43%
|
|
| American Uranium Limited (AMU) ORDINARY FULLY PAID |
Materials |
$16 |
Lo Herma Resource Drilling Timing Confirmed
|
2 Oct 2025 9:45AM |
$0.235 |
$0.150 |
fallen by
36.17%
|
|
AMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Lo Herma resource drilling expected to commence w/c 20 October 2025.
- Phase one drilling focuses on resource expansion.
- Hydrogeological testing to occur alongside phase one drilling.
- Targeting extensions of known trends to increase the resource base.
- Aims to convert Exploration Target Range mineralisation.
- Plans for updated Mineral Resource Estimate and revised Scoping Study in 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$8 |
Suspension from Quotation
|
2 Oct 2025 9:45AM |
$0.010 |
$0.004 |
fallen by
57.89%
|
|
RNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Renegade Exploration Limited requests voluntary suspension.
- Suspension due to clarification needed on mining claims.
- Securities suspended from 2 October 2025.
- Suspension to end on 6 October 2025 or upon announcement release.
- No additional market information needed regarding suspension.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canyon Resources Ltd (CAY) ORDINARY FULLY PAID |
Materials |
$495 |
Application for quotation of securities - CAY
|
2 Oct 2025 9:45AM |
$0.245 |
$0.240 |
fallen by
2.04%
|
|
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$164 |
Notification of cessation of securities - VVA
|
2 Oct 2025 9:45AM |
$1.840 |
$1.665 |
fallen by
9.51%
|
|
| Qmines Limited (QML) ORDINARY FULLY PAID |
Materials |
$37 |
Fully Underwritten $1.5m Share Purchase Plan
|
2 Oct 2025 9:44AM |
$0.063 |
$0.058 |
fallen by
7.94%
|
|
QML - Price-sensitive ASX Announcement
Full Release
Key Points
- Qmines Limited announces a Fully Underwritten $1.5m Share Purchase Plan (SPP).
- The SPP aims to offer new fully paid ordinary shares to existing eligible shareholders to raise $1.5 million.
- The proceeds will be used for exploration at the Mt Mackenzie gold and silver project and for general working capital.
- Canaccord Genuity (Australia) Pty Ltd is the Lead Manager; Global ESG Investments Limited is the Underwriter.
- Eligible shareholders can apply for up to A$30,000 worth of new shares at $0.055 per share.
- The SPP is fully underwritten and subject to shareholder approval at the upcoming AGM.
- This announcement has been authorized by the Board of QMines Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Southern Palladium Limited (SPD) ORDINARY FULLY PAID |
Materials |
$275 |
Southern Palladium presents to Sydney Mining Club
|
2 Oct 2025 9:44AM |
$1.010 |
$2.200 |
risen by
117.82%
|
|
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$3 |
Seaweed Sales Results Sustained Strong Performance
|
2 Oct 2025 9:44AM |
$0.002 |
$0.002 |
fallen by
25%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH Global Ltd reported gross sales of A$222,656 for the August Sales Period.
- Sales were made to wholesale buyers in Indonesia, with international shipments expected soon.
- Seaweed was sourced from partnerships with coastal farming communities in Indonesia.
- BP8 has a fully operational 550m² warehouse in Makassar, enhancing its independent operations.
- The company maintains a strong partnership with PT Kebula Raya Bestari.
- BP8's operations demonstrate sustained demand and strong sales momentum.
- The company is progressing international sales opportunities.
- BP8 aims to scale volumes and broaden customer reach in line with sustainability commitments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Scentre Group (SCG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$21,752 |
Scentre Group Prices EUR500m of Senior Notes
|
2 Oct 2025 9:43AM |
$4.100 |
$4.170 |
risen by
1.71%
|
|
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$774 |
Change of Director's Interest Notice
|
2 Oct 2025 9:42AM |
$4.310 |
$4.560 |
risen by
5.80%
|
|
| Highfield Resources Limited (HFR) ORDINARY FULLY PAID |
Materials |
$20 |
Voluntary Suspension Request
|
2 Oct 2025 9:42AM |
$0.067 |
$0.043 |
fallen by
35.82%
|
|
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$212 |
Reinstatement to Quotation
|
2 Oct 2025 9:42AM |
$0.020 |
$0.026 |
risen by
30%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Reinstatement to Quotation for Orion Minerals Ltd.
- Suspension of trading to be lifted immediately.
- Release of annual report for year ended 30 June 2025.
- Announcement regarding a capital raising.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$212 |
Proposed issue of securities - ORN
|
2 Oct 2025 9:42AM |
$0.020 |
$0.026 |
risen by
30%
|
|
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$212 |
Orion Increases Capital Raising to $7.7 million
|
2 Oct 2025 9:42AM |
$0.020 |
$0.026 |
risen by
30%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Orion increases capital raising to $7.7 million.
- Initial target was approximately A$5 million.
- Raised through placement of 515 million shares.
- Issue price set at 1.5 cents per share.
- Additional support from sophisticated and professional investors.
- Appendix 3B filing to follow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$8 |
Additional complete responses in CHM CORE-NK Phase 1b trial
|
2 Oct 2025 9:42AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics achieves additional complete responses in CORE-NK Phase 1b trial for AML.
- 57% of high-risk frontline subjects showed clinical responses.
- Two new complete responses were reported, supplementing previous findings.
- The ongoing trial is enrolling patients at MD Anderson Cancer Center and Case Western Reserve University.
- Combination treatment includes CORE-NK cells with azacitidine and venetoclax.
- The trial continues to show favorable safety with no unexpected adverse findings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
2 Oct 2025 9:41AM |
$0.005 |
$0.002 |
fallen by
60%
|
|
CTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Catalina Resources Ltd requested a trading halt.
- The trading halt is pending an announcement on exploration results.
- The halt will last until the announcement or 6th October 2025.
- The request follows ASX Listing Rule 17.1.
- The company is unaware of any reason for the halt not being granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.